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1. Introduction 
This chapter will describe the historical background, technical issues, outcomes, and future 
considerations of angioplasty to treat various congenital heart lesions in both the systemic 
and pulmonary arteries. Intravascular stent placement will be mentioned briefly, but the 
primary focus will be balloon angioplasty of arterial stenosis. Peripheral stenoses secondary 
to acquired arterial lesions will not be discussed. 
2. Coarctation of the aorta  
2.1 Historical background 
Coarctation of the aorta is a condition where the aorta is narrowed in the area where the 
ductus arteriosus inserts (Figure 1). Coarctation represents 5-10% of all congenital heart 
disease. Coarctation is more common in Caucasian than Asian individuals and is less 
common among Native Americans. Males are affected 1.6-1.8 times as often as females. The 
overall incidence of coarctation in the United States is 64 per 100,000. The presentation can 
range from shock in infancy after closure of the ductus arteriosus to systemic hypertension 
in early childhood to adulthood.  
The three treatment modalities for coarctation of the aorta are surgery, stent placement, and 
balloon angioplasty (BA). Candidates for BA will be discussed in detail below. In native 
coarctation of the aorta, the anatomy most suitable for BA is discrete, rather than diffuse, 
stenosis (Figures 2a and 2b). This is not necessarily the case in recurrent coarctation, where 
discrete or diffuse lesions secondary to surgical scarring are each amenable to BA. 1-3 
2.2 Neonates/infants 
Balloon angioplasty of coarctation of the aorta in neonates/infants can typically be 
performed with low-profile balloon angioplasty catheters due to the smaller final inflation 
diameter required in this age group. The most common diameter used in this age group is 6-
8 mm, although as the patient approaches 12 months of age, the diameter shifts to the 8-10 
mm range. The most commonly used balloons are the TyShak II balloons (NuMed Corp, 
Hopkington, New York). Up to 8 mm diameter balloons take an 0.021” wire, can be 
introduced through 4-Fr sheaths, and have a rated burst pressure (RBP) of at least 4 
atmospheres (ATMs). The 9-12 mm diameter balloons take an 0.025” (9-10 mm) or 0.035” (12 
mm) wire, can be introduced through 5-Fr sheaths, and have a RBP of 3.5 ATMs. TyShak 
Mini balloons (NuMed), with diameters from 4-10 mm, are even lower profile, using 3-Fr  
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Fig. 1. Coarctation 
 
 
Fig. 2. a-b. 
sheaths up to 8 mm diameter and 4-Fr sheaths for the 9-10 mm sizes. They take an 0.014” 
wire and can reach RBP of at least 3.5 ATMs. Most coarctations require 3 ATMs to obtain 
adequate dilation of the narrowed segment.  
On occasion, high-profile, non-compliant balloon angioplasty catheters may be required to 
adequately dilate the coarctation segment. There are numerous balloon angioplasty 
catheters available: PowerFlex series (4-12 mm diameter, Cordis Corp, Warren, New Jersey), 
Z-Med II balloons (4-30 mm diameter, NuMed), and Cook ATB (4-10 mm diameter, Cook 
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Corp, Bloomington, IN). Each are similar, although certain sizes of PowerFlex and ATB 
balloons can be advanced through sheaths that are 1-Fr size smaller than Z-Med II. Rarely, 
cutting balloons (CB) may be required for coarctation angioplasty.4 More specific 
information on CB will be given in the pulmonary angioplasty section. 
The standard approach for native or recurrent coarctation of the aorta is retrograde via 
femoral- or umbilical-arterial access. This approach offers the most direct route to treat the 
coarctation site. In very small infants (< 1.5 kg), alternative approaches have been reported 
(Figures 3a, 3b, and 3c).5 Angiograms of the coarctation and transverse aortic arch are 
performed prior to balloon angioplasty. In over 20% of patients, most commonly in cases of 
symptomatic neonatal/infant coarctation of the aorta, transverse aortic arch hypoplasia may 
be present. The definition of transverse aortic arch hypoplasia is a transverse arch-to-
descending aortic ratio of < 0.60.6-8  Measurements at the transverse aortic arch and 
descending aorta at the level of the diaphragm are made. The smaller of these diameters 
determines the size of the balloon catheter used to perform coarctation angioplasty. It is 
particularly important that the balloon be de-aired prior to inflation, as balloon rupture may 
cause air emboli into the brachiocephalic vessels. On initial inflation, one tries not to exceed 
a balloon-to-coarctation ratio of > 4:1.7 Pre- and immediately post-pressure measurements 
are obtained. After the angioplasty, it is extremely important to obtain standard and 
orthogonal angiographic views of the coarctation area to exclude a small dissection or 
aneurysm. If high pressure or cutting balloon catheters are required for adequate dilation of 
the coarctation segment, a covered stent should be available in the catheterization lab in case 
one encounters aneurysm formation, an acute dissection, or vessel tear.  
 
 
Courtesy of Prada F, et al. Rev Esp Cardiol. 2010 Jun;63(6):741-3. 
Fig. 3. a-c. Balloon angioplasty of a critical coarcation in a 1200 gram premature infant per 
the left carotid artery via a 3 Fr sheath using the Seldinger technique. A 4 mm TyShak Mini 
balloon was used with the coarctation segment increasing from 1.5 to 3.2 mm and a decrease 
in the systolic gradient from 35 to 7 mmHg. The infant developed recoarctation 2 months 
later and at 2200 grams underwent repeat balloon angioplasty from the femoral arterial 
system. At 6 months out from the procedure (5600 grams) the infant continues to do well 
with no evidence of recoarctation. 
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2.3 Outcomes 
Infantile coarctation of the aorta typically occurs in conjunction with severe heart failure or 
shock. In this setting, coarctation is frequently associated with other congenital heart lesions 
(bicuspid aortic valve in 60-70%, ventricular septal defect in 40%, and other left-sided 
lesions, i.e. mitral valve stenosis, subaortic valve stenosis, and hypoplastic left ventricle 3% 
of the time). Performance of coarctation angioplasty is not recommended in patients with 
associated congenital lesions requiring surgery. The predominant treatment for isolated 
native coarctation of the aorta presenting in infancy is surgical repair with extended end-to-
end anastomoses. Although many believe that surgical repair is the standard of care, some 
have advocated that BA in high-risk patients is a reasonable initial procedure to improve 
their surgical candidacy.9 The overall outcome of BA is poor in infants presenting in heart 
failure or shock. Liang et al. performed a recent study where they evaluated 18 infants with 
native coarctation of the aorta and congestive heart failure who underwent balloon 
angioplasty. The mean age was just less than three months and the mean body weight was 4 
kg. Congestive heart failure symptoms improved markedly in all patients immediately after 
BA. The incidence of re-coarctation was high in infants, requiring surgery if the systolic 
pressure gradient > 10 mmHg from ascending to descending aorta or if the coarctation 
diameter measured < 3 mm. The recurrent coarctation rate was 44% (8/18 patients) and the 
conclusion was that balloon angioplasty, in this setting, was ineffective and not 
recommended as a primary treatment alternative.9  
In another recent study by Rau, et al., 51 infants less than 3 months of age who presented 
with heart failure underwent balloon coarctation angioplasty from the umbilical artery 
(16/51), femoral artery (26/51) and femoral venous antegrade across the inter-atrial 
communication (9/51). Findings included acute reduction in the peak gradient across the 
coarctation segment, increase in the diameter of the coarctation segment, and improved 
symptomatology following BA. Effective palliation was achieved in 47/51 infants (92%). At 
intermediate follow-up, 22/51 (43%) developed re-coarctation withn three months after 
balloon angioplasty, requiring either repeat BA (14/22) or surgical (8/22) intervention. 
Using avoidance of surgery for four weeks as the definition of success, the authors 
concluded that BA is an excellent alternative to surgical intervention for the management of 
native coarctation in the neonatal period. With > 50% of patients requiring reintervention 
within 10 months of initial BA, we believe that surgical treatment of this condition remains 
the standard of care in this subgroup of patients. 10 
2.4 Challenges for the future 
The development of bioabsorable stents could potentially change this treatment paradigm. 
There are two current challenges with bioabsorable stent technology: (1) to reliably make a 
stent that can reach 6-7 mm diameter with adequate radial strength to overcome the 
coarctation; and (2) to be able to deliver the stent though a low profile sheath (4-5-Fr if 
performed retrograde and up to 7-Fr if performed antegrade from the venous route). There 
are currently two bioabsorbable stents being evaluated with the potential to enter clinical 
use in Europe within the next several years. 
3. Aortic coarctation in children and adults 
3.1 Historical overview 
Balloon angioplasty for the treatment of native or recurrent coarctation of the aorta has been 
performed since the mid 1980s.11 There is excellent data to support BA to treat recurrent 
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coarctation of the aorta in this age group. Although BA is considered the treatment of choice 
for this lesion in children and adults,12 controversy surrounds the use of BA for native 
coarctation of the aorta in these patients presenting with hypertension. 
3.2 Technique 
BA is performed from the retrograde femoral arterial route in the majority of children and 
adults undergoing BA for either recurrent or native coarctation. Recently, there have been 
reports of using radial access for recognition and treatment of potential complications, some 
advocating for BA though we, and others, feel radial access is more appropriate for stent 
treatment of coarctation of the aorta. 13 After a complete right and left heart catheterization 
is performed, the coarctation segment is approached retrograde from the descending to 
ascending aorta. It is important to rule out any potential left-sided lesions, including mitral 
valve stenosis, subaortic valve stenosis, or aortic valve stenosis, as these lesions can be also 
associated with coarctation of the aorta. Furthermore, significant diastolic dysfunction and 
increased diastolic pressures can be encountered in this patient group. For severe or nearly 
atretic coarctation of the aorta, crossing the narrowed segment retrograde may be quite 
difficult. Under those circumstances, transseptal technique is used to enter the left heart 
antegrade and the coarctation can then be crossed more easily from the ascending to 
descending aorta. Typically, either an angled 0.035” glide wire (Cook Corp, Bloomington, 
Indiana) or Wholey wire (Covidian Inc. Mansfield, MA) are used. The wire is then snared 
retrograde from the distal descending aorta and an arterial-venous loop is created, then 
allowing retrograde delivery of the balloon to the coarctation segment.  
 
   
Fig. 4. a-b. Comparison between the Atlas and Z Med II balloon catheters. The tapered 
shoulder on the Atlas balloon significantly increases the actual balloon length as well as 
inflation/deflation time in comparison to the shorter Z Med II balloon. 
www.intechopen.com
Angioplasty, Various Techniques and Challenges in  
Treatment of Congenital and Acquired Vascular Stenoses 
 
174 
Higher RBP for coarctation BA is more important as patients age. Although lower profile 
(TyShak II) balloons may be used, less compliant, higher profile balloon angioplasty 
catheters are usually required. PowerFlex, Maxi-Plus (Cordis corp, Warren, NJ), Z-Med II, 
Mullins (NuMed corp., Hopkington, NY), and Atlas (Bard Medical, Tempe, AZ) balloon 
angioplasty catheters have all been used. The Atlas balloon catheter has enhanced low 
profile (2-3 Fr sizes less than the others) and high RBP. The tapered shoulders of the Atlas 
balloon makes the balloon quite long and longer inflation/deflation times are required, 
making it more difficult to adequately position this balloon catheter across the coarctation 
segment (Figures 4a-b). 
As one exceeds 5-6 atmospheres of pressure to achieve successful dilation of the coarctation 
segment, there is an increased likelihood of creating an acute dissection, aneurysm, or in 
rare cases, rupture of the aorta.7 It has been recommended that one not exceed four times the 
narrowest coarctation segment during dilation in the initial setting. Patients with extremely 
tight coarctation segments therefore require a staged approach. 
3.3 Outcomes 
Balloon angioplasty of native coarctation of the aorta is part of the treatment paradigm in 
children and adults. In the Congenital Cardiovascular Interventional Study Consortium 
(CCISC) registry comparing surgical vs. stent vs. balloon angioplasty treatment of native 
coarctation of the aorta in children and adults, BA appeared to have an increased risk  
of aneurysm formation and dissection at short-term and intermediate follow-up (Tables 1 
and 2) (Journal American College of Cardiology, in press). The overall hemodynamic 
outcome related to blood pressure management and upper to lower extremity blood 
pressure gradient appear to be equal between the three groups at short-term and 
intermediate follow-up. In the subgroup of patients undergoing balloon angioplasty, the 
incidence of aneurysm formation was as high as 43% at intermediate follow-up, some 
patients requiring placement of a covered stent (Figures 5a-b). Cowley et al., in comparing 
surgery with balloon angioplasty for native coarctation of the aorta, showed that aneurysm 
formation and the need for re-intervention was significantly higher in the balloon 
angioplasty group compared to the surgical group.14 Hassan, et.al., looked at balloon 
angioplasty in the older adolescent and young adult populations only, age range from 14-54 
years. In this age group, the aneurysm rate was much lower (7%) at intermediate follow-
up.15, 16 The difference between these studies may be related to the age group of patients 
treated with balloon angioplasty. In the Forbes study, the mean age was 6.8 years vs. 22 
years in Hassan’s study. Perhaps older patients are more likely to have successful outcomes 
and less likely to have aneurysm formation following BA.  
The most severe complication, aortic rupture or large dissection, is rare, but occurs with 
increased incidence in older patients. As expected, it is the non compliant, adult aorta where 
this is more likely to occur. Aortic rupture or large aneurysm formation does not appear to 
be related to exceeding the balloon:coarctation ratios of 4:1, but may be related to exceeding 
6 ATMs during initial balloon inflation. In one case, a 43 yo lady with moderate 
hypertension and coarctation of the aorta presented for transcatheter treatment of the 
coarctation segment. BA was unsuccessful in relieving the gradient. Stent placement was 
performed using a high pressure balloon angioplasty catheter. At the end of the procedure, 
a small amount of contrast was observed outside of the stent posteriorly. CT scan revealed 
near complete transection of the aorta. One month and one year follow-up CT imaging 
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noted complete resolution of the peri-aortic hematoma with no evidence of dissection or 
aneurysm formation (Figures 6a-d). 
 
Outcomes 
Surgery 
(n = 26) 
Balloon 
(n = 28) 
Stent 
(n = 97) 
p-value 
(2-sided) 
Any Complications1 23.1% 32.1% 8.3% 0.003* 
Aortic Wall Injury (%) 11.5% 21.4% 3.1% 0.004* 
   Dissection / Intimal Tear (%) 0.0% 7.1% 0.0% 0.062 
   Aneurysm (%)  11.5% 14.3% 3.1% 0.040* 
Coarct / Dao ratio (mean) 0.91 0.73 0.82 0.003* 
Coarct / Dao ≥ 0.6 87% 79% 90% 0.247 
Any Re-obstruction 19.2% 32.1% 15.4% 0.057 
   Mild2 7.7% 17.9% 11.3%  
   Moderate 7.7% 3.6% 4.1%  
   Severe 3.9% 10.7% 0%  
1Defined as any moderate to severe reobstruction, aortic wall injury (aneurysm, dissection, intimal tear) 
or stent fracture.  
2Mild reobstruction was not considered as a complication in our analysis.  
* P- value < 0.05 
Table 1. Short-Term Follow-up Outcomes by Integrated Imaging 
 
 
Outcomes Surgery 
(n = 16) 
Balloon 
(n = 16) 
Stent 
(n = 56) 
p-value 
(2-sided) 
Any Complications1 25.0% 43.8% 12.5% 0.020* 
Aortic Wall Injury (%) 12.5% 43.8% 7.1% 0.003* 
   Dissection / Intimal Tear (%) 0.0% 6.3% 1.8% 0.598 
   Aneurysm (%)  12.5% 43.8% 5.4% <0.001 
Coarct / Dao ratio (mean) 0.98 0.79 0.80 0.011* 
Coarct / Dao ≥ 0.6 88% 93% 89% 1.000 
Any Re-obstruction 18.8% 18.8% 14.3% 0.923 
   Mild2 6.3% 18.8% 12.5%  
   Moderate 6.3% 0% 1.8%  
   Severe 6.3% 0% 0%  
1Defined as any moderate to severe reobstruction, aortic wall injury (aneurysm, dissection, intimal tear) 
or stent fracture.  
2Mild reobstruction was not considered as a complication in our analysis.  
* P- value < 0.05 
Table 2. Intermediate Follow-up Outcomes by Integrated Imaging 
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Fig. 5. a-b. 
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Fig. 6. a. 
 
 
 
   
Fig. 6. b-c. 
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Fig. 6. d. 
Re-obstruction, as defined as an upper to lower blood pressure gradient > 20 mmHg or 
narrowed segment > 50% of the native vessel diameter, appears to be less common as the 
age at the time of initial treatment increases. Re-obstruction frequency ranges from 3-20% in 
older children/adults undergoing primary BA of native coarctation compared to the nearly 
50% re-obstruction rate seen in infant balloon angioplasty of their native coarctation. 9, 10, 15 
3.4 Challenges for the future 
Stent treatment, particularly in older children and adults, appears to be the treatment of 
choice in treatment of native and recurrent coarctation of the aorta.7, 8, 13, 17 Permeating 
balloons, where a drug is injected into the vessel wall during angioplasty to prevent the 
development of re-stenosis, have not been successful for adequate drug delivery in animal 
studies. The primary challenge involves unintentional delivery of the drug directly into the 
blood stream, and not into the vessel wall. Placement of markers 5 mm apart, marking the 
permeating holes within the balloon catheter may assist us in delivering the treatment drug 
directly into the vessel wall, though this remains to be seen. The length of time for inflation 
required to deliver the medication (1-3 minutes) would require adequate collateralization 
around the coactation lesion to decrease the likelihood of encountering lower 
Peri-aortic 
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extremity/bowel ischemia. The current medications that may have a role in this are similar 
to the current medications being placed on drug eluting stents. These can be broken down 
into cytotoxic/cytostatic drugs, which have recently been undergoing head-to-head trials in 
applications to coronary stenting 18, 19 20 or “pro-healing” drugs such as endogenous growth 
factors or endothelial progenotor cells.21 What role, if any, in this approach to coarctation of 
the aorta, remains to be seen.  
4. Pulmonary artery stenosis 
4.1 Historical background 
Balloon angioplasty, first described for use in pulmonary valve stenosis in 1983,22 has 
become the treatment of choice for balloon angioplasty of branch pulmonary artery stenosis 
in most pediatric cardiology centers. 23, 24 Surgical repair of branch pulmonary artery 
stenosis has been sub-optimal, associated with increased morbidity, especially in young 
infants and children. 
4.2 Technique 
As with any interventional procedure, the first step in evaluating a pulmonary artery for BA 
is to understand the anatomy and pathophysiology of the stenotic lesion to be addressed. 
Generally, as in coarctation of the aorta, discrete lesions tend to be more amenable to BA 
compared to long segmental lesions. In Figures 7a-c, a patient with Tetralogy of Fallot with 
pulmonary valve atresia has multiple discrete and long segment stenosis of the right upper 
lobe segment. BA is performed both in the distal discrete stenosis and the more proximal 
long segment stenosis. Follow up imaging noted resolution of the distal discrete stenosis 
with persistence of the proximal stenosis, which required stent placement. In another patient 
with RPA stenosis following the arterial switch procedure (Figure 8), MRI imaging shows 
the RPA stenosis to be secondary to posterior compression from the aorta. Therefore stent 
placement, not BA, was necessary to treat this mechanical RPA stenosis.  
Performance of branch pulmonary artery BA is relatively straightforward and can be 
through a short sheath. The most difficult part of the procedure is usually crossing the 
stenotic segment. Accurate angiographic imaging is essential. For proximal stenosis (prior to 
the takeoff of the upper lobe branch), the lesion is crossed with either a 0.025 or 0.035” wire 
where, depending on patient size, a 4-5 Fr pigtail or multipurpose catheter is advanced over 
the wire into the stenosed pulmonary artery. Hand or power angiography is performed. For 
distal branch stenosis, the stenotic lesion is usually crossed with a glide wire and then a 4-Fr 
JB-1 or similar glide catheter (Cook Corp, Bloomington, IN) is advanced over the wire distal 
to the lesion. Hand injections can be performed through the catheter with the wire 
remaining in place. BA is usually carried out over that same wire. If multiple lobar segments 
are involved, the BA catheter is pulled back into the proximal pulmonary arterial segment 
and the soft tipped 0.018” wire is used to cross other stenoses. Stent treatment of multiple 
branch PA stenosis is usually not recommended, as many of the affected branch vessels 
would be “jailed off” by the stent (Figure 9a-b). 
The balloons typically required for branch pulmonary artery BA are the higher-pressure, 
non-compliant balloon catheters. Typically, the more distal or peripheral the stenosis, the 
greater the need for higher atmosphere balloons or cutting balloons (or both) to achieve 
adequate BA of the stenotic segment.  
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Fig. 7. a-c. Patient with Pulmonary Atresia and Ventricular Septal Defect with multiple 
distal stenosis of the RPA segment. BA is performed up to 19 ATMs with a 4 mm balloon 
angioplasty catheter. Left lower panel notes resolution of the distal discrete stenosis, though 
persistence of the proximal stenosis.  
The cutting balloon (CB) is a dilation balloon made of noncompliant modified polyethylene 
terephthalate with available balloon diameters from 2-8 mm and lengths 10, 15, and 20 mm 
(Boston Scientific Corp., Natick, Massachusetts, Figure 10 a-b). The incremental increase in 
balloon size is 0.25 mm from 2-4 mm and 1 mm from 5-8 mm. Depending on the balloon 
diameter, 3 or 4 microsurgical blades are attached every 90 or 120 degrees, each blade with a 
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working height of 0.11-0.18 mm. Prior to dilation, the folds of the balloon cover the 
microsurgical blades and following dilation, the blades wrap into the folds of the balloon with 
deflation. Use of the CB requires a long sheath, 4-Fr for a 4 mm CB, 6-Fr for a 5 mm CB, and 7-
Fr for a 6-8 mm CB. Wires are 0.014” up to 4 mm diameter and 0.018” from 5-8 mm diameter. 
These balloons reach full inflation at 6 ATMs with burst pressure at 10 ATMs. Aggressive 
balloon angioplasty of the vessel (up to 22 ATM pressure) with a standard balloon angioplasty 
catheter is usually performed prior to performing CB. (Figure 11a-d). The CB is usually dilated 
1-2 mm larger than the narrowest segment of the stenosis. Following this, standard BA is 
performed up to the native vessel size. The balloons may undergo repeat dilation, but it is 
recommended that no more than 10 inflation/deflation cycles be used for one balloon catheter. 
Rapid inflation and deflation of CB should not be performed; rather slowly inflating and 
deflating these balloons over a one minute period of time is recommended. Finally, exceeding 
the burst pressure of these balloons should never be undertaken. Balloon rupture, which 
typically is longitudinal, prevents the proper folding of the balloon and subsequent coverage 
of the microblades, thereby making it more likely to strip a blade off the balloon catheter 
during removal of the CB. CB angioplasty is performed via either long flexor sheaths (Cook 
Flexor, Cook corp, Bloominton, IN) or various guiding sheaths. 
 
 
Fig. 8. 
Patients with multiple bilateral peripheral pulmonary artery stenoses can suffer from re-
perfusion injury following dilation of multiple affected lung segments. This situation can be 
life threatening in patients who are already compromised with severe elevation of the right 
ventricular pressure. Multiple techniques have been addressed in an attempt to avoid this 
circumstance. One is to dilate one segment or pulmonary arterial side with no treatment of 
the contralateral side at the same cath procedure.  Another is selectively ventilating the 
contralateral lung segment during the BA procedure, thereby decreasing blood flow to the 
treated lung and theoretically decreasing the likelihood of encountering re-perfusion injury 
of those involved segments. 25 
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Courtesy Allison Cabalka, Mayo Clinic, Rochester, MN 
Fig. 9. a-b. Multiple right and left pulmonary artery stenosis of the distal branches. Patient 
has systemic right sided pressures and is planning on undergoing multiple balloon 
angioplasty dilations. One can see discrete as well as diffuse stenosis of the distal branch 
vessels.  
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Fig. 10. a-b. 
4.3 Outcomes 
The performance of pulmonary balloon valvuloplasty to treat pulmonary valve stenosis has 
been an extremely effective procedure. Unfortunately, balloon dilation of stenoses of the 
pulmonary arteries distal to the pulmonary valve has not been as satisfactory.23, 26 Although 
the stenotic vessels often can be dilated with angioplasty balloons, even to three or four 
times the original size, the stenoses frequently recur immediately after balloon deflation. 
The recurrence of obstruction following dilation is thought to be due to the natural elastic 
recoil of the tissue in native pulmonary arterial stenosis or to resilience and resistance of scar 
tissue in postoperative cases. Rothman, et al. reported the only large series of balloon 
pulmonary artery dilations in 135 patients. 27 They noted that previous reports of surgery for 
the direct relief of pulmonary artery lesions was difficult and often ineffective.28 The mean 
diameter of the lesion increased from 3.8 +/- 1.7 to 5.5 +/- 2.1 mm with dilation (p = 0.001). 
The overall success rate was 58% (127/218 dilations), assessed by the following criteria: an 
increase greater than or equal to 50% of predilation diameter, an increase greater than 20% 
in flow to the affected lung, or a decrease greater than 20% in systolic right ventricular to 
aortic pressure ratio. A pulmonary artery aneurysm occurred in 5% of the pulmonary 
arteries dilated. Two patients died at angioplasty. Restenosis occurred in 16% of the 
restudied patients with initial successful dilation. They concluded that balloon angioplasty 
was an established, highly useful procedure in the management of branch pulmonary artery 
stenosis. 27 
The use of cutting balloons (CB) has increased the success rate of pulmonary artery BA from 
50-60% to 80%, irrespective of whether CB were used de novo or following failure of 
standard balloon angioplasty.26 One area where CB have been particularly effective is in 
severe, multiple discrete stenosis of the distal pulmonary arterial branches (Figure 9a-b). 29, 30  
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Courtesy Jaqueline Kreutzer, Children’s Hospital of Pittsburgh, Pittsburgh, PA 
Fig. 11. a-d. Cutting balloon angioplasty of distal branch left lower lobe pulmonary artery 
stenosis. Upper left panel notes the stenotic segments of the left lower lobe branches. Right 
upper panel notes failed aggressive balloon angioplasty at 18 ATMs. Left lower panel, 
successful cutting balloon dilation of the stenotic segment. Right lower panel, resolution of 
the left lower lobe stenosis following cutting balloon angioplasty.  
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This is a rare condition that can be idiopathic or associated with William’s/Alagille 
syndrome. 29, 31 Primary stenting is generally not recommended for these lesions due to the 
likelihood of jailing off adjacent pulmonary arterial branches. Balloon angioplasty of these 
lesions almost always requires high-pressure balloons and in many cases is resistant to 
standard BA. 23 Aneurysm, dissection, and vessel perforation have been associated with BA 
of pulmonary artery stenosis, with one patient having a late rupture of an aneurysm with 
subsequent death. 32 These procedures can be tedious but the outcomes, over time, can be 
dramatic. 
Surgical repair of pulmonary arterial stenosis has also been ineffective and carries 
considerably greater morbidity and probably greater mortality. 28 Surgical problems with 
these lesions relate to the location of the narrowings, often in the distal branch pulmonary 
arteries, an area difficult to reach from a standard midline sternotomy or lateral 
thoracotomy. Recurrent stenosis has been reported in up to 31% of patients who had 
surgical repair of the right pulmonary artery after Waterston shunt placement.28 
4.4 Challenges for the future 
Although BA has its limitations, it remains a very important treatment modality for 
pulmonary and systemic arterial stenosis. CBs have improved the treatment of resistant 
lesions. The improvement of balloon technology has significantly decreased the number of 
vascular complications over the past 15 years. Drug delivery through permeable balloons 
(see section under Challenges for the Future in Coarctation) has significant potential 
application for the treatment of stenosis in the pulmonary arterial system. The tolerance of 
longer inflation times and smaller vessel size observed in the pulmonary arterial system 
makes this a technically easier undertaking in comparison to attempting drug delivery in 
the systemic arterial system.  
5. Conclusion 
Balloon angioplasty has proven to be successful in the treatment of pulmonary artery 
stenosis and coactation of the aorta. Significant challenges remain, primarily in the 
prevention of recurrent stenosis. The development of biodegradable stents and permeable 
balloon catheters will undoubtedly improve outcomes for both pulmonary artery and aortic 
coarctation angioplasty, most importantly in the area of restenoses. 
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